Ticker League

Cash on Hand for Bristol-Myers Squibb (BMY)

As of · Reported

Metric

Latest period

$10.49B

YoY change

-1.7%

5Y CAGR

-8.3%

Peak year (2021)

$17.22B

Cash on Hand history chart for Bristol-Myers Squibb (BMY) from 1987 to 2025

Latest: $10.67B

Cash on Hand growth chart for Bristol-Myers Squibb (BMY) from 1987 to 2025

Latest: -1.7%

Cash on Hand history table for Bristol-Myers Squibb (BMY) from 1987 to 2025

  • 2025$10.67B-1.7%
  • 2024$10.86B-11.6%
  • 2023$12.28B+32.7%
  • 2022$9.25B-46.3%
  • 2021$17.22B+4.7%
  • 2020$16.45B+6.9%
  • 2019$15.39B+75.7%
  • 2018$8.76B+28.6%
  • 2017$6.81B+7.3%
  • 2016$6.35B+48.7%
  • 2015$4.27B-42.6%
  • 2014$7.43B+64.3%
  • 2013$4.53B+60.0%
  • 2012$2.83B-67.6%
  • 2011$8.73B+19.6%
  • 2010$7.30B-14.2%
  • 2009$8.51B+3.0%
  • 2008$8.27B+271.5%
  • 2007$2.23B-44.6%
  • 2006$4.01B-30.8%
  • 2005$5.80B-22.4%
  • 2004$7.47B+34.4%
  • 2003$5.56B+39.4%
  • 2002$3.99B-29.4%
  • 2001$5.65B+67.0%
  • 2000$3.38B+14.5%
  • 1999$2.96B+31.8%
  • 1998$2.24B+54.1%
  • 1997$1.46B-13.4%
  • 1996$1.68B+2.2%
  • 1995$1.65B+0.2%
  • 1994$1.64B-32.2%
  • 1993$2.42B+13.3%
  • 1992$2.14B+48.9%
  • 1991$1.44B+140.8%
  • 1990$596.00M+16.9%
  • 1989$510.00M-79.7%
  • 1988$2.51B+7.0%
  • 1987$2.35B—

Cash on Hand values are taken from Bristol-Myers Squibb's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Cash on Hand at Bristol-Myers Squibb (BMY)

According to Bristol-Myers Squibb's latest reported financial statements, the company's latest reported cash and short-term investments is $10.49B. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for net leverage and total assets for the share of assets held in cash.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

In 2025, Bristol-Myers Squibb (BMY) cash and short-term investments totalled $10.67B – edged down 1.7% year-over-year.

Bristol-Myers Squibb cash and short-term investments has contracted on net over the period, with a -8.3% compound annual growth rate over 2020–2025 (5 years).

Between 2021 and 2025, Bristol-Myers Squibb cash and short-term investments plunged 38.0%, falling from $17.22B to $10.67B.

2021 marks the peak cash and short-term investments at $17.22B, with the historical low of $510.00M recorded in 1989.

Bristol-Myers Squibb Cash on Hand by Year

Bristol-Myers Squibb Cash on Hand 2025: $10.67B

Bristol-Myers Squibb posted cash and short-term investments of $10.67B in 2025, edged down 1.7% below 2024.

Bristol-Myers Squibb Cash on Hand 2024: $10.86B

In 2024, Bristol-Myers Squibb reported cash and short-term investments of $10.86B, declined 11.6% below 2023.

Bristol-Myers Squibb Cash on Hand 2023: $12.28B

Bristol-Myers Squibb cash and short-term investments in 2023 was $12.28B, surged 32.7% from 2022.

Bristol-Myers Squibb Cash on Hand 2022: $9.25B

2022's cash and short-term investments for Bristol-Myers Squibb came in at $9.25B, plunged 46.3% below 2021.

Bristol-Myers Squibb Cash on Hand 2021: $17.22B

Bristol-Myers Squibb cash and short-term investments in 2021 was $17.22B.

See more financial history for Bristol-Myers Squibb (BMY).

Sector peers by Cash on Hand

Healthcare peers of Bristol-Myers Squibb (BMY), ranked by their latest cash and short-term investments

Frequently asked questions

Bristol-Myers Squibb (BMY) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview